{
    "clinical_study": {
        "@rank": "154576", 
        "arm_group": {
            "arm_group_label": "Study cohort", 
            "description": "Subjects visiting the hospital with suspected bacterial meningitis in The Philippines and Vietnam."
        }, 
        "biospec_descr": {
            "textblock": "Cerebrospinal Fluid (CSF) sample (collected as part of routine practice)"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This study aims to provide an estimate of the proportion of suspected cases of bacterial\n      meningitis that are due to N. meningitidis and the serogroup responsible in The Philippines\n      and Vietnam."
        }, 
        "brief_title": "Neisseria Meningitidis Burden of Disease Study", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Infections, Meningococcal", 
        "condition_browse": {
            "mesh_term": "Meningococcal Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who the investigator believes can and will comply with the requirements of\n             the protocol or subjects who the investigator believes that parent(s)/Legally\n             Acceptable Representative(s) [LAR(s)] can and will comply with the requirements of\n             the protocol.\n\n          -  Written informed consent obtained from the subject/from the parent(s)/LAR of the\n             subject.\n\n          -  A male or female subject who visits the hospital with suspected bacterial meningitis.\n\n          -  CSF sample taken as part of routine practice.\n\n        Exclusion Criteria:\n\n          -  Child in care."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects visiting the hospital with suspected bacterial meningitis in The Philippines and\n        Vietnam."
            }
        }, 
        "enrollment": {
            "#text": "521", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01730391", 
            "org_study_id": "114989"
        }, 
        "intervention": [
            {
                "arm_group_label": "Study cohort", 
                "description": "Collection of demographic data and vaccination history", 
                "intervention_name": "Data collection", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Study cohort", 
                "description": "CSF samples will be tested for the determination of N. meningitidis and other likely bacterial pathogens that cause bacterial meningitis (S. pneumoniae and H. influenzae)", 
                "intervention_name": "CSF samples testing", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Baguio City, Benguet", 
                        "country": "Philippines", 
                        "zip": "2600"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quezon City", 
                        "country": "Philippines", 
                        "zip": "1102"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hanoi", 
                        "country": "Vietnam", 
                        "zip": "084"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Philippines", 
                "Vietnam"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Neisseria Meningitidis Burden of Disease", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Philippines: Philippines Food and Drug Administration", 
                "Vietnam: Ministry of Health"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Prevalence of N. meningitis in CSF samples", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }, 
            {
                "measure": "Serogroup of N. meningitis positive samples", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01730391"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Further characterization of N. meningitidis using Multi Locus Sequence Typing", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }, 
            {
                "measure": "Prevalence of Haemophilus influenzae and Streptococcus pneumoniae in CSF samples as causes of bacterial meningitis", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }, 
            {
                "measure": "Serotype of Streptococcus pneumoniae positive samples", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }, 
            {
                "measure": "Further classification of Haemophilus influenzae positive samples into Type B and non-B Types", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }, 
            {
                "measure": "Total number of subjects with suspected bacterial meningitis (according to diagnostic criteria used by each participating hospital to identify this condition)", 
                "safety_issue": "No", 
                "time_frame": "At enrollment (Day 0)"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}